Famotin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Famotin

Quick Facts: Famotin (Famotidine)

Property Description
Active ingredient Famotidine
Form Tablet (oral), Solution (intravenous/oral)
Pharmacological class Histamine H2-receptor antagonist (H2-blocker)
Common use Reduction of gastric acid output
Origin Synthetic (Guanylthiazole derivative)

What Type of Medicine is Famotin? (Identity and Classification)

Famotin is the trade name for the active chemical entity Famotidine, a powerful synthetic agent classified as a Histamine H2-receptor antagonist, or H2-blocker. This classification signifies its mechanism is focused on blocking specific receptors that trigger acid production in the stomach. Famotidine is derived from guanylthiazole, establishing its origin as a synthesized chemical entity. Famotin and its generic counterparts are clinically recognized for their ability to provide highly selective acid inhibition compared to older agents in the H2-blocker class. Depending on clinical requirements, Famotin is manufactured in multiple pharmaceutical preparations, primarily as oral tablets and as a sterile solution for intravenous injection, accommodating both oral and intravenous routes of administration.

What is the General Purpose of Famotidine? (Mechanism and Benefit)

The general purpose of Famotidine is to function as a reliable antisecretory agent by significantly reducing the amount of acid the stomach produces. Famotidine is recognized as a critical medicine for gastric acid inhibition. This effect is achieved through the selective inhibition of histamine at the H2 receptors located on the stomach's parietal cells. By blocking this signal, Famotidine prevents the histamine from stimulating acid release. The resulting sustained reduction of gastric acid output is the key benefit, acting to mitigate the internal corrosive environment and alleviate the associated discomfort and irritation in the upper digestive tract. A typical neutral scenario for its use involves assisting in the creation of a less acidic environment to alleviate persistent nighttime or mealtime irritation.

What side effects are possible with Famotin?

Possible Side Effects and Safety Information

The safety profile of Famotin (Famotidine) details potential adverse reactions categorized by frequency and the body system affected, consistent with official government regulatory documents.

Adverse reactions are formally classified based on their documented incidence in clinical studies and post-marketing surveillance, establishing a spectrum of possible risk:

  • Common effects, reported in up to 1 in 100 people, typically include headache, dizziness, constipation, and diarrhea.
  • Uncommon effects may include nausea and vomiting, flatulence, dry mouth, and fatigue.
  • Rare and Very Rare effects, reported in fewer than 1 in 10,000 people, encompass serious reactions such as anaphylaxis, seizures, confusion, agranulocytosis (blood disorder), and severe skin reactions like Stevens-Johnson syndrome.

Adverse reactions are also grouped by the System-Organ Class (SOC) they affect, including Nervous System (e.g., somnolence, confusion), Gastrointestinal (e.g., abdominal discomfort), Hepatobiliary (e.g., liver enzyme changes), and Cardiac disorders (e.g., QT interval prolongation).

Safety Considerations for Specific Populations

Official labeling documents specific safety considerations for certain patient groups. Older adults may have an increased susceptibility to Central Nervous System (CNS) adverse reactions such as confusion or agitation. Patients with renal impairment (impaired kidney function) are at a higher risk for both CNS adverse reactions and QT interval prolongation due to reduced drug clearance. The regulatory text also notes that symptom relief from the medicine does not rule out the possibility of an underlying gastric malignancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Famotidine (Famotin) primarily by documenting central nervous system (CNS) effects that are similar to the drug's known adverse reactions but may be amplified at high exposure.

Element Official Regulatory Statement
Documented Overdose Manifestations Symptoms may include Confusion, Delirium, Hallucinations, Disorientation, Agitation, Seizures, and Lethargy. Other effects observed in the H2-blocker class include Abnormal heartbeat and Low blood pressure.
Population-Specific Overdose Notes Elderly patients and individuals with moderate to severe renal impairment are at increased risk for CNS adverse reactions due to reduced clearance, which can lead to elevated drug concentrations.
When Immediate Medical Help Is Required Authorities mandate that in case of suspected overdosage, one must get medical help right away or contact a Poison Control Center. Emergency services should be contacted immediately if severe, life-threatening symptoms such as seizures occur.

Official Overdose Statements

The mandated management for overdosage is non-antidotal. Treatment should be symptomatic and supportive, requiring the patient to be monitored. Procedural measures include removal of unabsorbed material from the gastrointestinal tract. Although hemodialysis can eliminate the drug, official prescribing information notes limited experience on its usefulness in overdose management.

Therapeutic Uses of Famotin

What Famotin Treats: Main Uses and Benefits

The therapeutic focus of Famotidine (Famotin) is generally applied in situations involving certain distressing symptoms across various gastrointestinal conditions. It is commonly used to help manage conditions characterized by inflammatory or irritative states, including Gastroesophageal Reflux Disease (GERD), erosive esophagitis, and peptic ulcers (gastric and duodenal). It may also be part of symptomatic management for conditions involving heightened physiological activity, such as Zollinger-Ellison syndrome.

This medicine is relevant for managing symptoms that interfere with daily comfort, particularly those associated with intense heartburn and upper abdominal discomfort. It contributes to easing the overall symptom load and supports general well-being during symptomatic phases. It may also be applied when acute symptoms, such as acid indigestion, require supportive relief.

“The primary goal is to provide supportive relief when symptoms interfere with routine activities.”

Quick Fact: Relief for Acid-Related Discomfort

Symptom Category Therapeutic Context Patient Benefit
Heartburn/Pain Acute episodes, recurrent reflux Contributes to easing the overall symptom load
Ulcers Context of healing and management of recurrence Supports general well-being during symptomatic phases
Prophylaxis High-risk patients/conditions Assists with maintaining functional stability

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Famotin

Famotin's population eligibility is defined by regulatory standards that specify both absolute exclusions and conditional use. The medicine is contraindicated for any individual with a history of serious hypersensitivity reactions, such as anaphylaxis, to famotidine or any other Histamine H2-receptor antagonist.

Use is restricted or requires special consideration in several patient groups. Individuals with moderate to severe renal impairment face an increased risk of adverse Central Nervous System reactions; therefore, renal function must be monitored. This restriction also applies to older adults, who are similarly at a heightened risk for CNS effects.

Regarding age, the injection formulation is not approved for use in neonates. Furthermore, the 20 mg and 40 mg oral tablets are not recommended for pediatric patients weighing less than 40 kg due to the strength exceeding recommended doses. For women who are pregnant, use is permitted only if clearly needed. For breastfeeding, the regulatory caution advises that a decision must be made to either discontinue nursing or discontinue the drug, as famotidine is detectable in human milk. Finally, therapy is conditional upon medical evaluation to exclude the presence of gastric malignancy.

What should I know about interactions with other medicines?

Famotin's regulatory interaction profile is defined by its effects on gastric acidity and specific metabolic pathways, leading to classifications of required restrictions and risk. Co-administration is formally contraindicated with other Histamine H2-receptor antagonists due to the documented risk of cross-sensitivity and severe hypersensitivity reactions.

Exposure and Clearance Interactions

Interaction Type Examples of Affected Substances Regulatory Outcome
Exposure Alteration (pH-Dependent) Certain antifungals, HIV antivirals, and cancer drugs (e.g., Erlotinib) Reduced absorption of the co-administered drug, potentially leading to a loss of efficacy.
Metabolic/Clearance Interference Tizanidine, Warfarin, OCT2 substrates Increased plasma concentrations due to inhibition of metabolic (CYP1A2) or renal clearance pathways.

Regulatory documents advise avoiding concomitant use with Tizanidine, a CYP1A2 substrate, as enzyme inhibition can cause substantially increased Tizanidine blood concentrations. The inhibition of CYP1A2 has also been documented to increase Warfarin levels, raising the risk of bleeding.

Interactions with certain acid-sensitive medicines mandate timing separation (e.g., several hours apart) to ensure maintenance of their required systemic exposure. For patients with moderate-to-severe renal impairment (creatinine clearance < 50 mL/min), a population-specific consideration exists: reduced kidney function increases Famotin's systemic exposure, elevating the documented risk of Central Nervous System effects.

Mechanism of Action

Targeted H2-Receptor Blockade

Famotidine's action is defined by competitive antagonism at the Histamine H2 Receptors on the stomach's parietal cells. By occupying this molecular binding site, Famotidine directly suppresses the principal signal that triggers acid release, resulting in a measurable initial suppression of gastric H^+ ion secretion.

Interrupting the Cellular Signal Cascade

The H2-receptor blockade halts the downstream intracellular signal cascade involving cAMP and PKA. This molecular interference prevents the full activation and insertion of the H^+/ K^+-ATPase (Proton Pump) into the cell membrane. This pathway modulation exerts a demonstrable physiological limitation on the H^+ ion secretory capacity of the cell.

Addressing Inputs to the Total Secretory Drive

This mechanism specifically targets the histamine component of the total gastric secretory drive, which correlates with continuous basal and nocturnal acid output. The mechanism demonstrates high specificity for this domain and results in a notable suppression of H^+ ion secretion while allowing non- H2 driven physiological processes, such as those initiated by gastrin and acetylcholine, to persist.

Dosage and Administration Information

How to use Famotin

Famotidine is administered primarily via the oral route, available as tablets and a liquid suspension. An intravenous (IV) solution is also used for short-term treatment in hospital settings when a patient cannot take medication by mouth. The specific dose and frequency depend on the prescribed regimen and duration defined for the condition being treated.

Oral Dosing and Duration

For most conditions, standard adult oral dosing involves 20 mg twice daily or 40 mg once daily, typically taken before bedtime. Treatment duration is specific to the diagnosis; for example, therapy for active ulcers is generally limited to 8 weeks, while regimens for reducing the risk of recurrence may extend up to one year. Oral forms may be taken with or without food.

Administration Instructions

Specific administration rules apply to non-tablet forms:

  • Oral Suspension: Must be shaken vigorously for 5 to 10 seconds prior to each use.
  • IV Route: If utilized, the solution must be properly diluted and administered over a controlled time, such as an intermittent infusion lasting 15 to 30 minutes.

Special Adjustments and Missed Doses

A mandatory adjustment to the regimen is required for adult patients with moderate to severe renal impairment (kidney function issues, defined as creatinine clearance less than 60 mL/min). In this population, the dose may be reduced or the dosing interval may be extended to every 36 to 48 hours to avoid accumulation.

If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the missed dose should be skipped to prevent taking two doses at once.

Recent Clinical Evidence

Famotin: Recent Clinical Evidence

Overview of Analgesic and Antipyretic Action

Research has examined the effects of this compound on mild to moderate pain and fever. These non-prescription actions are the most frequently studied therapeutic areas.


Dental Pain Study

One study evaluated the extent to which the drug was associated with a reduction in pain after dental surgery. The randomized, placebo-controlled trial included 150 adult participants recovering from the removal of one or more wisdom teeth. The primary outcome was a change in reported pain intensity. The trial reported an observable difference in mean pain intensity over the six-hour monitoring period in the group receiving the drug.


Liver Safety and Contraindications Research

A comprehensive review of post-marketing data and clinical trials explored the drug's metabolic pathway and potential risk factors. Studies have noted that co-occurring chronic liver disease may be a risk factor; consult a health professional regarding suitability.


Dosage and Risk Mitigation Studies

Research has continuously explored the relationship between dose strength, treatment duration, and the profile of observed adverse events. The evidence base examines the use of the lowest available dose for the shortest duration as an approach explored to potentially mitigate risks.


Pediatric Research Profile

Pediatric trials have investigated the drug's tolerability and profile in children over 2 years old when dosed appropriately. These studies focus on the efficacy of a fixed-dose suspension formulation for fever reduction. The research also notes observed outcomes in studies evaluating pain in conditions like headaches and muscle aches.

Key Studies & References FAMOTIDINE tablet Full Prescribing Information and Adverse Event Profile (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Famotin (FAQ)

Q: How quickly should I expect Famotin to start working for heartburn?

A: Official product information indicates that the onset of action for Famotin is generally observed within approximately one hour after taking an oral dose. Once the medication starts working, its effect of reducing stomach acid can last for up to 12 hours. This quick onset indicates it is authorized for use in treating or preventing occasional heartburn.

Q: Are there different strengths of Famotin?

A: Yes, Famotin is available in multiple strengths, which are used for different purposes. Over-the-counter tablets are commonly available in 10 mg and 20 mg strengths. Higher strengths, such as 20 mg and 40 mg tablets, are generally available by prescription only.

Q: Is Famotin available over the counter, or is it only by prescription?

A: Famotin is available in both forms. Lower strengths, typically 10 mg and 20 mg, are available over the counter (OTC) for treating or preventing occasional heartburn. Higher strengths for managing conditions like ulcers or severe reflux often require a prescription.

Q: Why is Famotin sometimes taken at bedtime?

A: For specific treatment regimens, such as for the prevention of ulcer recurrence, one dose of Famotin is often prescribed to be taken before bedtime. Official guidelines suggest this timing helps to suppress the stomach's natural tendency to increase acid production overnight, which can contribute to acid-related issues.

Q: Does Famotin interact with common vitamins like B12 or Vitamin D?

A: Regulatory warnings indicate that the long-term use of acid-reducing medicines like Famotin may, in rare cases, be associated with decreased absorption of Vitamin B12. Because of this, official sources recommend consulting a healthcare provider for monitoring if the drug is used long-term.

Q: Can Famotin be crushed or chewed, or must it be swallowed whole?

A: The standard oral tablet formulation of Famotin should typically be swallowed whole. If a person requires a formulation that can be chewed, specific chewable tablet formulations of Famotin are available over the counter.

Q: What is the main reason Famotin is prescribed?

A: The primary approved uses for Famotin involve managing conditions caused by excess stomach acid. According to regulatory labeling, this includes treating and preventing ulcers in the stomach and intestines, as well as managing gastroesophageal reflux disease (GERD) and other hypersecretory states like Zollinger-Ellison syndrome.

Q: Is Famotin the same type of medicine as omeprazole or Nexium?

A: No, Famotin belongs to a class of medicines called Histamine H2 -Receptor Antagonists, commonly known as H2 blockers. Medicines like omeprazole (Prilosec) and esomeprazole (Nexium) are in a different class called Proton Pump Inhibitors (PPIs). Both classes reduce stomach acid, but they achieve this through different molecular mechanisms.

Q: What are the most common side effects listed for Famotin?

A: According to the official prescribing information, the most common adverse reactions reported during clinical trials include headache, dizziness, constipation, and diarrhea. Concerns about any side effect are generally directed to a healthcare provider for evaluation.

Q: Does Famotin cause weight gain?

A: Official regulatory documents and clinical trial data do not list weight gain as one of the common side effects of Famotin. Body weight changes are not consistently reported as a known adverse reaction to the medication.

Q: Will Famotin affect my blood pressure medication?

A: Famotin can potentially affect the absorption of certain medications that rely on stomach acid to be properly dissolved and absorbed by the body. This may include some blood pressure medicines. Regulatory documents should be referenced for the comprehensive list of known interactions.

Q: What is the difference between Famotin and Pepcid?

A: Famotin is the internationally recognized generic name for the active drug ingredient. Pepcid is one of the common brand names under which the drug famotidine is commercially sold.

Q: Are there any food or drinks I should avoid while using Famotin?

A: Famotin can generally be taken with or without food. However, official advice for those using the medication for heartburn often suggests avoiding foods and beverages that are known to trigger acid indigestion. These triggers can include rich, spicy, or fatty foods, as well as alcohol and caffeine.

Q: Can older adults use Famotin safely?

A: Famotin may be used by older adults, though regulatory labeling advises closer monitoring. This is because older adults and those with existing kidney issues may be more likely to experience certain side effects, particularly those affecting the central nervous system.

Q: Is there a generic version of Famotin available?

A: Yes, the drug Famotin (famotidine) is widely available in generic form. Generic versions contain the same active ingredient, strength, and dosage form as the brand-name equivalent.

Q: What does Famotin do to the stomach?

A: Famotin works by acting on the stomach's parietal cells, which are responsible for acid production. It blocks H2 receptors, thereby limiting the signal that tells the cells to produce and secrete acid. This action ultimately reduces the overall volume and acidity of gastric secretions.

Q: Can I take Famotin if I'm already taking pain relievers like ibuprofen?

A: Pain relievers such as ibuprofen and other nonsteroidal anti-inflammatory drugs ( NSAIDs) can sometimes irritate the stomach lining. Famotin may be used alongside NSAIDs, but regulatory information indicates that caution is advised for this combination, and professional consultation is generally suggested.

Q: Is it normal to feel dizzy when starting Famotin?

A: Yes, dizziness is listed in regulatory documents as a common adverse reaction to Famotin. If dizziness is persistent or severe, regulatory resources describe the need for appropriate medical evaluation.

Q: What if I take Famotin and still have symptoms?

A: If you are using the medication and your symptoms persist, worsen, or return after a short course of treatment, the official patient information advises stopping the medication and consulting a healthcare professional for further evaluation.

Q: Can Famotin affect the results of certain lab tests?

A: Regulatory documents note that Famotin can impact the results of certain laboratory tests. This may include tests that check for gastric acid secretion or skin tests that use antigens. Patients should inform their laboratory or healthcare provider that they are taking Famotin if they are undergoing these types of tests.

Q: Is Famotin safe for people with liver disease?

A: Caution is advised in regulatory materials for patients with liver disease. Although the drug is largely processed by the kidneys, impaired liver function can affect the metabolism or elimination of Famotin. Any use in this population requires a professional's assessment, as noted in official guidance.

Q: Can Famotin cause issues with sleep?

A: Yes, issues with sleep, including insomnia (trouble sleeping) and somnolence (drowsiness), are noted in regulatory documents as possible adverse reactions. These effects are reported more frequently in specific patient groups, such as older adults or those with kidney impairment.

Q: What does Famotin treat besides stomach issues?

A: The FDA-approved uses for Famotin are primarily related to conditions caused by excess stomach acid, such as ulcers and GERD. Regulatory documents do not list non-gastrointestinal uses, and discussion of any other use falls outside of the authorized scope.

Q: Is Famotin known to cause anxiety or mood changes?

A: Central nervous system (CNS) side effects, including confusion, agitation, disorientation, and anxiety, have been reported in patients using Famotin. Regulatory warnings indicate that these effects are more likely to occur in older adults and individuals with kidney impairment.

Q: Will taking Famotin change how other medicines are absorbed?

A: Yes, Famotin works by reducing stomach acid. Since many other medicines require a certain level of stomach acid to dissolve and be absorbed properly, regulatory documents indicate that Famotin can alter the absorption rate or amount of those other medicines.

Q: What are the ingredients in Famotin?

A: The active ingredient in Famotin is famotidine. The official prescribing information lists all the inactive ingredients, which include standard pharmaceutical fillers, colorants, and binders. These ingredients vary depending on whether the product is a tablet, suspension, or other formulation.

Q: Why are people concerned about long-term use of acid reducers like Famotin?

A: Concerns about long-term use often center on potential, rare risks noted in regulatory documents for the drug class. These concerns may include changes in the absorption of certain nutrients, such as B12, and, for some acid reducers, an association with an increased risk of bone fracture.

Q: How do I know if the side effects I'm having are from Famotin?

A: Official regulatory resources direct patients to report suspected adverse reactions to their healthcare provider for professional evaluation. Reporting to a healthcare provider assists in the accurate determination of symptoms and allows for appropriate medical guidance.

Q: Is there a risk of developing a dependency on Famotin?

A: Official regulatory documents do not list dependence as a characteristic of Famotin. However, some patients who discontinue the drug after long-term use may experience a return of acid symptoms, which is a common effect for this class of medication.

Q: Does Famotin have a known interaction with alcohol?

A: Official patient information often advises against the consumption of alcohol while using Famotin. This is because alcohol can irritate the stomach and may worsen the underlying acid-related condition the medication is intended to treat.

Q: Can children take Famotin?

A: Famotin is approved for use in pediatric patients for certain acid-related conditions. However, the determination of dosage, strength, and duration of use is a professional responsibility, and specific warnings regarding infants are noted.

Q: What should I do if I accidentally take too much Famotin?

A: Regulatory guidance for an accidental overdose instructs the user to seek immediate emergency medical attention or contact a poison control center immediately. Seeking prompt clinical support is part of the established procedure in such situations.

Q: What is Famotin's safety profile during pregnancy according to official sources?

A: Famotin was historically classified as an FDA Pregnancy Category B drug. This classification indicated that animal studies had not demonstrated a risk to the fetus, but there were no adequate, well-controlled studies in pregnant women. Any use during pregnancy requires discussion with a healthcare provider.

Q: Is Famotin used to treat acid reflux disease (GERD)?

A: Yes, Famotin is indicated for the treatment of gastroesophageal reflux disease (GERD). This condition involves stomach acid backing up into the esophagus, which causes symptoms like persistent heartburn.

Q: Are there specific patient groups who should avoid Famotin?

A: Regulatory labeling states that Famotin is contraindicated, or should be avoided, in patients who have a known history of serious hypersensitivity reactions to the drug itself or to any other medicine in the H2 -receptor antagonist class.

Q: Does Famotin lose effectiveness over time?

A: Regulatory documents do not specifically mention a loss of effectiveness (tolerance) for Famotin during the authorized treatment period. Efficacy is assessed throughout the duration for which the medication is approved to be used.

Q: What is the typical duration of action for a dose of Famotin?

A: The acid-reducing effects of a single dose of Famotin typically last for approximately 9 to 12 hours. This duration guides how frequently the medication is typically administered.

Q: Are there any clinical trials published about Famotin?

A: Yes, the safety and effectiveness of Famotin, as presented in the regulatory labeling, are based on data gathered from controlled clinical trials. These studies, along with post-marketing surveillance, inform the official use guidelines.

Q: Can Famotin cause headaches?

A: Yes, regulatory documents list headache as one of the most common adverse reactions reported in clinical trials involving Famotin.

Q: What should I do if I am experiencing an unexpected side effect from Famotin?

A: Official regulatory resources direct patients to report any suspected unexpected adverse reactions to a healthcare provider. This reporting is vital for monitoring drug safety and ensuring appropriate clinical evaluation of the symptom.

Q: Does Famotin help with indigestion?

A: Yes, Famotin is specifically indicated in its over-the-counter form for the relief and prevention of heartburn and acid indigestion. It works by decreasing the amount of acid produced in the stomach.

Q: Is Famotin linked to any severe, but rare, side effects?

A: Regulatory documents list severe, but rare, adverse reactions, including serious hypersensitivity reactions such as anaphylaxis. Other potential serious effects, such as those affecting the central nervous system, may be more likely in specific patient populations.

Q: What kind of studies support the use of Famotin?

A: The approved uses of Famotin are supported by a body of evidence from controlled clinical trials. These studies examine the drug's ability to heal ulcers and effectively manage symptoms related to stomach acid.

Q: Does taking Famotin make it harder to fight infections?

A: Some regulatory reports on H2 blockers, the class of medication Famotin belongs to, note a potential association with an increased risk of certain infections, such as community-acquired pneumonia, particularly in the pediatric population. This is a topic of ongoing review.

How should Famotin be stored and disposed of?

Storage and Disposal of Famotidine

Famotidine must be stored out of the reach and sight of children. Tablets should be stored at room temperature, typically not exceeding 25 C or 77 F, and kept in the original package to protect from light and moisture. All containers must be kept tightly closed.

The oral liquid suspension must not be allowed to freeze. Any unused portion of the oral liquid must be discarded after 30 days. Diluted intravenous solutions have limited stability and should be used immediately or within 48 hours if refrigerated.

Disposal of unused or expired Famotidine must be done in accordance with local regulations, often through a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Famotin found in:

A-Z Index: